EICHOR

Recruiting studies: Infectious Pneumonia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
Phase N/A · 1 location(s) · Guangzhou 8th People's Hospital · NCT06145828 Fosfomycin I.v. for Treatment of Severely Infected Patients
Phase N/A · 50 location(s) · Infectopharm Arzneimittel GmbH · NCT02979951 Clazakizumab vs. Placebo - COVID-19 Infection
Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT04494724 Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units
NA · 12 location(s) · Hospital Israelita Albert Einstein · NCT07233837 Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotyp
Phase 3 · 26 location(s) · Nantes University Hospital · NCT06269900 Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Phase 3 · 464 location(s) · AstraZeneca · NCT05624450 Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT04491292 Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
Phase 2 · 1 location(s) · University of New Mexico · NCT06940609 Water-based Activity to Enhance Recovery in Long COVID-19
NA · 1 location(s) · VA Office of Research and Development · NCT06142253 Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Phase 2 · 67 location(s) · Synairgen Research Ltd. · NCT06999603 Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Phase 3 · 28 location(s) · Ansun Biopharma, Inc. · NCT03808922 Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05242159 Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
NA · 1 location(s) · University of Maryland, Baltimore · NCT05977179 VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024
Phase N/A · 1 location(s) · Centre Hospitalier Sud Francilien · NCT07181824 Imaging Immune Activation in COVID-19
Phase 2 · 1 location(s) · CellSight Technologies, Inc. · NCT04815096 Longterm Influence of Pediatric Long COVID Syndrome
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT05566392 COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
Phase N/A · 1 location(s) · Indiana University · NCT07128095 Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT04474301 Dime La VerDAD: Verify, Debunk, and Disseminate
NA · 4 location(s) · University of Chicago · NCT06417762 Long-term Impact of Infection With Novel Coronavirus (COVID-19)
Phase N/A · 1 location(s) · University of California, San Francisco · NCT04362150 Effects of Hydrotherapy During Post-COVID-19 Rehabilitation
NA · 1 location(s) · Schön Klinik Berchtesgadener Land · NCT07013903 Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-COVID-19 Syndrome
NA · 1 location(s) · University of Nove de Julho · NCT06248151 Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
Phase 2/Phase 3 · 24 location(s) · Hellenic Institute for the Study of Sepsis · NCT05926505 Antihistamines, Amantadine and Evolution of COVID-19
Phase N/A · 2 location(s) · Consorci Sanitari de Terrassa · NCT05504057 The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19
Phase N/A · 1 location(s) · N5 Sensors · NCT06571136 Long COVID Brain Fog: Cognitive Rehabilitation Trial
NA · 1 location(s) · University of Alabama at Birmingham · NCT06095297 Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
Phase N/A · 1 location(s) · Tufts Medical Center · NCT05866952 Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients
Phase N/A · 1 location(s) · Universitair Ziekenhuis Brussel · NCT07134673 Study of AHB-171 in Chronic Hepatitis B Participants
Phase 2 · 10 location(s) · Ausper Biopharma Co., Ltd. · NCT07630727 Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
Phase 3 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06960928

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →